Synapto ^Companies

Synapto is an early stage medical technology venture that aims to make Alzheimer's diagnosis more accessible. They utilize portable EEG and AI technology to provide accurate and efficient diagnosis. Synapto has received validation from reputable institutions such as NIH and UMD, and has been featured in publications like Forbes and Washingtonian. With plans for commercialization in the near future, Synapto is poised to revolutionize the field of Alzheimer's diagnosis.